AlphaMadera's AlphaVal page computes The Coca-Cola Company's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag KO as undervalued, fairly valued, or overvalued.

What is The Coca-Cola Company's fair value?

Fair value for KO is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value KO?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from KO's most recent reported fundamentals.

KO - The Coca-Cola Company

Price: -- -- | CONSENSUS: Buy DETAILS | PRICE TARGET: $86.38 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 80% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Overvalued Mild

Trading 12.6% above fair value

Current Price $83.49

Bear Case $63.52 23.9% downside ($63.52 - $83.49) / $83.49 = -23.9% $3.28 × 18x P/E

Fair Value $74.12 11.2% downside ($74.12 - $83.49) / $83.49 = -11.2% $3.28 × 21x P/E

Bull Case $84.71 1.5% upside ($84.71 - $83.49) / $83.49 = 1.5% $3.28 × 24x P/E

Adjust Assumptions

P/E Multiple

21.0x

Adjusted EPS

3.28$

Key Value Driver

Normalized P/E multiple (21x base case)

Implied Market Multiple 25.5x

Plain-Language Summary

Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $86.38 from 48 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $74.12 per share.

Warnings

ℹ Dividend-based valuation: $52.37 (below our primary estimate by 24%). Large gaps may signal the dividend doesn't reflect full earning power.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples